Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma

@inproceedings{Zhang2018SurgicalSA,
  title={Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma},
  author={Chao Zhang and Haitang Yang and Baoping Lang and Xiangdong Yu and Peng Xiao and Dian Hua Zhang and Liwen Fan and Xiao Jian Zhang},
  booktitle={Cancer management and research},
  year={2018}
}
Background Primary adenosquamous carcinoma (ASC) of the lung is a rare and aggressive disease. The accurate diagnosis of ASC based on small biopsies is challenging because of the mixed components within the tumor, and this may lead to suboptimal treatment. Furthermore, information about the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in lung ASC is limited. Patients and methods Data on a cohort of patients with lung ASC who underwent surgery between… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Improved survival associated with a balanced structure between adenomatous and squamous components in patients with adenosquamous carcinoma of the lung.

  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2016
VIEW 2 EXCERPTS

Squamous Cell Carcinoma "Transformation" Concurrent with Secondary T790M Mutation in Resistant EGFR-Mutated Adenocarcinomas.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2016
VIEW 1 EXCERPT